Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathologic features the urologist should expect on a prostate biopsy.

Mingxin Che1, Wael Sakr, David Grignon

  • 1Department of Pathology, Harper University Hospital, Wayne State University, Karmanos Cancer Institute, 3990 John R, Detroit, MI 48201, USA. mche@dmc.org

Urologic Oncology
|July 15, 2003
PubMed
Summary

Pathological evaluation of prostate biopsies has improved, providing crucial data beyond cancer detection. Accurate reporting of Gleason score and cancer extent guides patient management and counseling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>TGFBR1</i>*6A and Risk for Colorectal Cancer.

Cancer communications (London, England)·2026
Same author

Archaeological evidence of intensive indigenous farming in Michigan's Upper Peninsula, USA.

Science (New York, N.Y.)·2025
Same author

Augmentation Mastopexy: A Five-step Standardized Strategy Approach.

Plastic and reconstructive surgery. Global open·2022
Same author

p62/SQSTM1-induced caspase-8 aggresomes are essential for ionizing radiation-mediated apoptosis.

Cell death & disease·2021
Same author

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.

The American journal of surgical pathology·2020
Same author

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.

The American journal of surgical pathology·2020

Area of Science:

  • Uropathology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate biopsy evaluation has advanced significantly in accuracy and detail.
  • Pathological findings are critical for diagnosing and managing prostate cancer.

Purpose of the Study:

  • To review key pathological findings in prostate biopsies.
  • To discuss their interpretation, reporting, and clinical significance.
  • To highlight predictors of clinical outcome and diagnostic standards.

Main Methods:

  • Review of major pathological findings on prostate biopsy.
  • Discussion of interpretation, reporting, and clinical utility.
  • Emphasis on Gleason score and cancer extent in needle core biopsies.

Related Experiment Videos

Main Results:

  • Pathology reports offer more than cancer presence/absence; they provide vital clinical information.
  • Gleason score and cancer extent predict outcomes after prostatectomy or radiation.
  • Current standards for high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation are highlighted.

Conclusions:

  • Prostate biopsy pathology reports are essential for guiding patient management and counseling.
  • Accurate pathological assessment is key to effective prostate cancer treatment planning.
  • Understanding diagnostic nuances improves clinical decision-making.